Which parameter should be monitored in testosterone replacement therapy due to potential hematocrit increase?

Which parameter should be monitored in testosterone replacement therapy due to potential hematocrit increase?

• A. Hematocrit
• B. Hemoglobin
• C. Creatinine
• D. ALT

Answer: (A)

Testosterone replacement can stimulate red blood cell production, which can raise the hematocrit—the percentage of blood that's made up of red cells. A higher hematocrit thickens the blood and increases the risk of clotting, so tracking this value is essential during therapy. Baseline hematocrit should be obtained, with follow-up checks typically every 3–6 months in the early treatment period and then at intervals once stable. If hematocrit rises above a safety threshold (often around mid-50s percent), clinicians may reduce the testosterone dose, pause therapy, or perform therapeutic phlebotomy to lower the red cell mass. Creatinine and ALT monitor kidney and liver function, but they don’t directly signal the risk from increased red cell mass. Hemoglobin can rise with polycythemia as well, but hematocrit is the primary measure used to assess this specific risk because it reflects the proportion of red cells in the blood.

Testosterone replacement can stimulate red blood cell production, which can raise the hematocrit—the percentage of blood that's made up of red cells. A higher hematocrit thickens the blood and increases the risk of clotting, so tracking this value is essential during therapy. Baseline hematocrit should be obtained, with follow-up checks typically every 3–6 months in the early treatment period and then at intervals once stable. If hematocrit rises above a safety threshold (often around mid-50s percent), clinicians may reduce the testosterone dose, pause therapy, or perform therapeutic phlebotomy to lower the red cell mass. Creatinine and ALT monitor kidney and liver function, but they don’t directly signal the risk from increased red cell mass. Hemoglobin can rise with polycythemia as well, but hematocrit is the primary measure used to assess this specific risk because it reflects the proportion of red cells in the blood.